Robyn Ward
country of citizenship: Australia
educated at: University of New South Wales
occupation: medical researcher, physician
Articles 256
-
Challenges in valuing and paying for combination regimens in oncology: reporting the perspectives of a multi-stakeholder, international workshop
-
Queensland Genomics: an adaptive approach for integrating genomics into a public healthcare system
-
Evaluating genetic and genomic tests for heritable conditions in Australia: lessons learnt from health technology assessments
-
What are the attitudes of health professionals regarding patient reported outcome measures (PROMs) in oncology practice? A mixed-method synthesis of the qualitative evidence
-
Tumour infiltrating lymphocyte status is superior to histological grade, DNA mismatch repair and BRAF mutation for prognosis of colorectal adenocarcinomas with mucinous differentiation
-
Diagnostic and health service pathways to diagnosis of cancer-registry notified cancer of unknown primary site (CUP)
-
Correlation between initial tumour volume and treatment duration on Dabrafenib: observation study of subjects with BRAF mutant melanoma on the BRF112680 trial
-
Pathways to a cancer-free future: a protocol for modelled evaluations to minimise the future burden of colorectal cancer in Australia
-
Global approaches to genomic medicine implementation
-
Implementing gene curation for hereditary cancer susceptibility in Australia: achieving consensus on genes with clinical utility
-
Extrapolation of Survival Curves Using Standard Parametric Models and Flexible Parametric Spline Models: Comparisons in Large Registry Cohorts with Advanced Cancer
-
Health-related predictors of cancer registry-notified cancer of unknown primary site (CUP)
-
Demographic, social and lifestyle risk factors for cancer registry-notified cancer of unknown primary site (CUP)
-
Association of ten gastrointestinal and other medical conditions with positivity to faecal occult blood testing in routine screening: a large prospective study of women in England
-
The predicted impact and cost-effectiveness of systematic testing of people with incident colorectal cancer for Lynch syndrome
-
What is multidisciplinary cancer care like in practice? a protocol for a mixed-method study to characterise ambulatory oncology services in the Australian public sector
-
Evaluation of the transferability of survival calculators for stage II/III colon cancer across healthcare systems
-
Scarcity of Recurrent Regulatory Driver Mutations in Colorectal Cancer Revealed by Targeted Deep Sequencing
-
Disruption of a -35 kb Enhancer Impairs CTCF Binding and Expression in Colorectal Cells
-
Current mismatch repair deficiency tumor testing practices and capabilities: A survey of Australian pathology providers
-
Reduced nuclear DNA methylation and mitochondrial transcript changes in adenomas do not associate with mtDNA methylation
-
MACROD2 Haploinsufficiency Impairs Catalytic Activity of PARP1 and Promotes Chromosome Instability and Growth of Intestinal Tumors
-
Long-term survival in trastuzumab-treated patients with HER2-positive metastatic breast cancer: real-world outcomes and treatment patterns in a whole-of-population Australian cohort (2001–2016)
-
Mutation burden and other molecular markers of prognosis in colorectal cancer treated with curative intent: results from the QUASAR 2 clinical trial and an Australian community-based series
-
Lymphocytic response to tumour and deficient DNA mismatch repair identify subtypes of stage II/III colorectal cancer associated with patient outcomes.
-
Cost-effectiveness analysis of germ-line BRCA testing in women with breast cancer and cascade testing in family members of mutation carriers.
-
Guidance for Modifying the Definition of Diseases: A Checklist
-
Incidence and severity of self-reported chemotherapy side effects in routine care: A prospective cohort study
-
Towards a global cancer knowledge network: dissecting the current international cancer genomic sequencing landscape
-
Use and outcomes of targeted therapies in early and metastatic HER2-positive breast cancer in Australia: protocol detailing observations in a whole of population cohort
-
Trastuzumab for metastatic breast cancer: Real world outcomes from an Australian whole-of-population cohort (2001-2016).
-
Factors associated with participation in colorectal cancer screening in Australia: Results from the 45 and Up Study cohort.
Human - wd:Q30503543